Palo Alto event showcases Harvard tech startup formation

Agreement enables development of genome-based therapies to protect against heart disease in adults

Based on innovations from Harvard University and Boston Children's Hospital, Nocion Therapeutics aims to selectively silence pain and itch neurons

Developed through Harvard’s Blavatnik Biomedical Accelerator, innovations could lead to novel cell therapies to treat disease